-
admin
Posts
Packaging Printing Market to Grow by $46.3 Billion Over the Next 5 Years, Despite High Initial Investments for Advanced Printing Technologies and Machinery
Dublin, Oct. 25, 2024 (GLOBE NEWSWIRE) — The “Packaging Printing Market by Printing Ink, Material, Technology, Application – Global Forecast 2025-2030” report has been added...
Bahrain Opens the Largest ISF Gymnasiade in History
MANAMA, Bahrain, Oct. 25, 2024 (GLOBE NEWSWIRE) — In a remarkable display of global unity and athletic prowess, the 17th edition of the International School...
The Club de las 25 honors six prestigious women for their fight for equality in the 27th edition of its Awards
The Cervantes Institute was the stage chosen yesterday to present six awards to women, from various fields, for their struggle in favor of equality between...
Celldex Announces Upcoming Late Breaking Oral Presentation of 12 Week Results from Barzolvolimab Phase 2 Study in Chronic Inducible Urticaria at ACAAI 2024
HAMPTON, N.J., Oct. 25, 2024 (GLOBE NEWSWIRE) — Celldex Therapeutics, Inc. (NASDAQ:CLDX) announced today that 12 week results from the Company’s Phase 2 clinical trial...
Alvotech Meeting Investors and Presenting at the Jefferies 2024 London Healthcare Conference on November 19–20, 2024
Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, announced today its participation in the...
Tonix Pharmaceuticals to Present at the 2024 ThinkEquity Conference
CHATHAM, N.J., Oct. 25, 2024 (GLOBE NEWSWIRE) — Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a fully-integrated biopharmaceutical company with marketed products...
Alvotech Meeting Investors and Presenting at the Jefferies 2024 London Healthcare Conference on November 19–20, 2024
REYKJAVIK, Iceland, Oct. 25, 2024 (GLOBE NEWSWIRE) — Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for...
Acasti Announces Corporate Name Change to Grace Therapeutics, Inc.
Name Change Reflects Extensive Scientific and Corporate Brand Equity Previously Established under Grace Therapeutics Grace Therapeutics will begin trading on Nasdaq under the trading symbol...
MicuRx Announces the Successful Completion of Phase 1 Clinical Trial of MRX-5 in Australia
SHANGHAI, Oct. 25, 2024 /PRNewswire/ — Recently, Shanghai MicuRx Pharmaceutical Co., Ltd. (“MicuRx”, 688373.SH) announced the successful completion of Phase I clinical trial of MRX-5 in...
Over 1,000 Industry Representatives Participated in New World Development’s 1.5°C Summit 2024 with the First Eco-market Promoting Sustainable Living
HONG KONG, Oct. 25, 2024 /PRNewswire/ — Organized by New World Development, the fourth edition of the “The 1.5°C Summit – The Defining Decade for...
